Intech Investment Management LLC Purchases 4,143 Shares of Encompass Health Co. (NYSE:EHC)

Intech Investment Management LLC grew its stake in Encompass Health Co. (NYSE:EHC - Free Report) by 31.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 17,514 shares of the company's stock after purchasing an additional 4,143 shares during the quarter. Intech Investment Management LLC's holdings in Encompass Health were worth $1,617,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. MassMutual Private Wealth & Trust FSB grew its stake in Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock valued at $27,000 after purchasing an additional 137 shares during the period. Avior Wealth Management LLC bought a new position in Encompass Health during the third quarter valued at about $40,000. CBIZ Investment Advisory Services LLC increased its holdings in Encompass Health by 38.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after buying an additional 127 shares during the last quarter. Tompkins Financial Corp bought a new stake in Encompass Health in the fourth quarter worth about $46,000. Finally, V Square Quantitative Management LLC boosted its stake in Encompass Health by 43.8% in the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock valued at $54,000 after acquiring an additional 177 shares during the last quarter. 97.25% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms recently commented on EHC. William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. Barclays boosted their target price on Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a research note on Friday, February 7th. Royal Bank of Canada reiterated an "outperform" rating and set a $110.00 price target on shares of Encompass Health in a research note on Tuesday, February 11th. StockNews.com upgraded Encompass Health from a "hold" rating to a "buy" rating in a research note on Saturday, February 15th. Finally, KeyCorp increased their target price on shares of Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a research report on Monday, February 10th. Ten equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, Encompass Health has an average rating of "Buy" and an average price target of $107.67.

Remove Ads

Encompass Health Price Performance

Shares of EHC stock traded down $0.54 on Wednesday, reaching $100.33. The company's stock had a trading volume of 503,931 shares, compared to its average volume of 687,709. The company has a market capitalization of $10.10 billion, a P/E ratio of 22.50, a PEG ratio of 2.31 and a beta of 0.92. Encompass Health Co. has a 12-month low of $77.09 and a 12-month high of $104.55. The stock's 50 day simple moving average is $98.28 and its 200-day simple moving average is $97.26. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The company reported $1.17 EPS for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. As a group, equities analysts predict that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be paid a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.68%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health's dividend payout ratio is currently 15.25%.

Insider Transactions at Encompass Health

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the business's stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the sale, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 2.10% of the company's stock.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.